BiotechTube
Home/TikoMed/Björn Pilström
BP

Björn Pilström

Chief Executive Officer & Chief Medical Officer

TikoMed

Therapeutic Areas

Neurodegenerative DiseasesCardiovascular

TikoMed Pipeline

DrugIndicationPhase
ILB® for ALSAmyotrophic Lateral SclerosisPhase 2
ILB® for Myocardial InfarctionHeart AttackPre-clinical / Planning

Leadership Team at TikoMed

HO
Henrik Otendal
Chief Financial Officer
AW
Anita Westin Tocaj
Head of Regulatory Affairs
AB
Antonio Bermejo Gomez
Head of CMC
EE
Erika Egrelius
Head of Quality Assurance
JO
Johan Olsson
Head of Accounting
SD
Staffan Dahlgren
Head of Drug Safety
View full TikoMed profile